[PRESS RELEASE] – EDMONTON, Alberta, Dec. 11, 2025 – Aurora Cannabis Inc., the Canadian-based leading global medical cannabis company, announces the launch of Black Jelly, a proprietary cultivar, in Poland, expanding the company's portfolio of high-potency medical cannabis products in one of Europe's fastest-growing markets.
Grown and manufactured in Aurora's Canadian GACP and EU-GMP certified facilities, Black Jelly joins Farm Gas and Sourdough under the Cannabis flos Aurora brand portfolio.
"Aurora is uniquely positioned to bring this novel proprietary cultivar to the Polish market thanks to the company's advanced genetic breeding program and unmatched global cultivation excellence," said Andreas Dotterweich, senior vice president of Aurora Europe. "We deeply understand that prescribers want reliable, high-potency medical cannabis options for their patients, and we're proud to offer superior products that consistently meet prescriber and patient needs."
Black Jelly will be available for Polish prescribers starting Dec. 11, offering a cannabinoid profile of THC 27% / CBD <1%. A high-THC sativa derived from Alien Cake 3030 × T037, Black Jelly features dense, large flowers with green and orange hues and a terpene profile characterized by sweet black licorice and fruity undertones. The cultivar originates from Aurora's world-leading genetics program and is crafted using premium hang-drying and curing techniques.
Aurora continues to strengthen its leadership in international medical cannabis, leveraging its scientific expertise, regulatory knowledge and commitment to innovation to support patient access and market growth across Europe. With more than a decade of experience in global medical markets, Aurora remains the trusted partner in advancing Poland's medical cannabis ecosystem.
